Have you been eager to see how Ventas, Inc. (VTR) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this Chicago, IL-based healthcare real estate investment trust (“REITâ€) earnings release this morning:
A FFO Beat
Ventas came out with first-quarter 2015 normalized funds from operations (“FFOâ€) per share of $1.18, beating the Zacks Consensus Estimate of $1.13.
Elevated revenues were primarily responsible for this earnings beat.
How Was the Estimate Revision Trend?
Ventas has a decent earnings surprise history. Before posting an earnings beat in Q1, the company delivered positive surprises in three out of trailing four quarters. Overall, the company surpassed the Zacks Consensus Estimate by an average of 0.90% in the trailing four quarters.
Revenue Came In Higher Than Expected
Ventas posted revenues of $884 million, which beat the Zacks Consensus Estimate $831 million. Further, it compared favorably with the year-ago number of $741.5 million.
Key Developments to Note:
Ventas has increased its 2015 normalized FFO per share outlook to $4.67 – $4.75 as against $4.63 – $4.71 guided earlier. The new outlook range marks a 4–6% growth in normalized FFO per share from 2014 level.
What Zacks Rank Says
Ventas has a Zacks Rank #2 (Buy). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. While things apparently look favorable, it all depends on what sense the just-released report makes to the analysts.
